Page 14 - Sesen Bio Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Iovance Biotherapeutics Appoints Wendy L Dixon, Ph D , to Board of Directors

Iovance Biotherapeutics Appoints Wendy L Dixon, Ph D , to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomJen saundersSara pellegrinoIovance biotherapeuticsWendyl dixonArvinas incBoards of directors incyte corporationUniversity of cambridgeIovance biotherapeutics incDiamond therapeutics incOrexigen therapeuticsMarketing at merck coArdea biosciences incWomen affinity networkVoyager therapeutics incDrug administration

Iovance Biotherapeutics (IOVA) Names Wendy Dixon, Ph D to Board

Iovance Biotherapeutics (IOVA) Names Wendy Dixon, Ph D to Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomWendyl dixonArvinas incBoards of directors incyte corporationUniversity of cambridgeDiamond therapeutics incIovance biotherapeutics incOrexigen therapeuticsMarketing at merck coArdea biosciences incWomen affinity networkVoyager therapeutics incFuriex pharmaceuticalsDentsply internationalEleven biotherapeutics incBoards of directors alkermes plc

Sesen Bio (NASDAQ:SESN) Stock Rating Lowered by StockNews com

Sesen Bio (NASDAQ:SESN – Get Rating) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Saturday. Separately, TheStreet upgraded shares of Sesen Bio from a “d” rating to a “c-” rating in a research note on Friday, May 27th. Shares of SESN opened at $0.73 on […]

United statesAdvisor group holdings incSesen bio incAmerican international group incRoyal bankSesen bioGet ratingGroup holdingsInternational groupNasdaq sesnStocknews com

2022-05-09 | NDAQ:SESN | Press Release

(2022-05-09 | NDAQ:SESN) Sesen Bio Reports First Quarter 2022 Financial Results and Business Update

Bio closecurlyquoteAstrazeneca closecurlyquoteExchange commissionCompany closecurlyquoteEczacibasi pharmaceuticals marketingSesen bio incDrug administrationUs national cancer instituteHikma pharmaceuticalsBiologics license applicationSesen bioTypec meetingComplete response letterRoche license agreementRoche licenseAnnual meeting

Sesen Bio (SESN) – Analysts Recent Ratings Updates

Sesen Bio (NASDAQ: SESN) recently received a number of ratings updates from brokerages and research firms: 4/29/2022 – Sesen Bio was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Sesen Bio Inc. is a late-stage company developing next-generation antibody-drug conjugate therapies for patients with cancer. […]

United statesThomson reuterAdvisor group holdings incZacks investment researchSesen bio incAmerican international group incRoyal bankSesen bioBio incGet ratingGroup holdingsInternational groupNasdaq sesn